Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction (scientific article)

Early- and late-term clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.

Q51200327

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

Q73854850

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Q22306356

One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors

Q28221394

Derivation and validation of a risk standardization model for benchmarking hospital performance for health-related quality of life outcomes after acute myocardial infarction

Q33920774

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release

Q34522451

Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial

Q34615195

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

Q34659902

Thirty-day readmission rates for Medicare beneficiaries by race and site of care

Q35903588

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.

Q35949260

Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry

Q36036740

Thirty-day rehospitalizations after acute myocardial infarction: a cohort study

Q36474491

International variation in and factors associated with hospital readmission after myocardial infarction

Q39668127

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Q44928926

Finding pure and simple truths with administrative data

Q45189665

P433

issue

P921

main subject

acute coronary syndrome

Q266018

revascularization

Q7317735

P577

publication date

2015-02-09

P1433

published in

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Q19880670

P1476

title

Risk factors for rehospitalization for acute coronary syndromes and unplanned revascularization following acute myocardial infarction

P478

volume

Reverse relations

cites work (P2860)

Q33647497	ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
Q26765362	Acute Coronary Syndromes in Women: Recent Treatment Trends and Outcomes
Q59794225	All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with tr
Q37206349	Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction
Q37076132	Change in Angina Symptom Status After Acute Myocardial Infarction and Its Association With Readmission Risk: An Analysis of the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUM
Q58129806	Clinical Profile of Acute Myocardial Infarction Patients Included in the Hospital Readmissions Reduction Program
Q37240339	Clinical Relevance of Rehospitalizations for Unstable Angina and Unplanned Revascularization Following Acute Myocardial Infarction
Q64082627	Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US
Q64277095	Frailty and acute coronary syndrome: does gender matter?
Q64996975	Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction.
Q38623577	Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
Q92612114	Hospital Readmissions after Acute Coronary Syndromes
Q36134009	Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
Q26769988	Population-level differences in revascularization treatment and outcomes among various United States subpopulations
Q92663071	Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology "Ignacio Chávez"
Q55423937	Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction.
Q49556897	The impact of acute coronary syndrome on late drug-eluting stents restenosis: Insights from optical coherence tomography.

P356	DOI	10.1161/JAHA.114.001352
P932	PMC publication ID	4345868
P698	PubMed publication ID	25666368